Executive Summary
On December 23, 2025, an unprecedented 43 US companies across diverse sectors filed 8-K Item 5.02 disclosures on boardroom changes, including officer/director departures, appointments, elections, or compensatory arrangements—all uniformly neutral in sentiment with low materiality (2-4/10) and lacking any specific details on individuals, positions, reasons, or impacts. This synchronized spike suggests seasonal year-end governance housekeeping, batch regulatory compliance, or a broader undisclosed catalyst driving leadership churn, rather than isolated events. Cumulative implications are limited due to opacity, but the volume signals potential sector-wide board refreshes with minimal immediate market disruption; institutional investors should monitor for emerging patterns in full filings.
Tracking the trend? Catch up on the prior US Corporate Board Director Changes SEC Filings digest from December 21, 2025.
Investment Signals(5)
- ▲
Routine disclosures without disclosed controversies or forced exits [BULLISH] - All 43 companies
- ▲
Active board management across sectors amid year-end period [BULLISH] - Financials (e.g., Simmons First National, Peapack Gladstone) and biotech (e.g., Ginkgo Bioworks, Krystal Biotech)
- ▲
No quantitative compensation red flags or dilution signals [BULLISH] - Broad market
- ▲
Tech leaders like ServiceNow maintaining governance cadence [NEUTRAL] - ServiceNow, Skillz, Grid Dynamics
- ▲
Entertainment firms signaling stability continuity [NEUTRAL] - Six Flags, National CineMedia, Comcast
Risk Flags(4)
- ▼
Extreme filing concentration (43 on single day) with zero specifics raises systemic transparency concerns and potential hidden instability
- ▼
Cluster of 7+ financial institutions (e.g., Simmons First, USCB Financial) amid banking sector pressures
- ▼
Biotech cluster (7+ firms like NanoVibronix, high risk-rated) vulnerable to leadership voids in R&D-heavy environment
- ▼
Uniform opacity prevents correlation analysis, amplifying uncertainty for high-materiality names (e.g., ServiceNow, TransUnion)
Opportunities(4)
- ◆
Mine Item 9.01 exhibits across filings for undisclosed appointments/internal promotions yielding alpha in underfollowed small-caps (e.g., Optex Systems, Sharps Technology)
- Position for sector rotation◆
overweight stable large-caps (e.g., ServiceNow, Comcast) if patterns confirm routine refreshes
- ◆
Anticipate follow-on 4s or proxy disclosures revealing positive succession in biotech/financial clusters for M&A catalysts
- ◆
Short-term volatility plays on high-risk names (e.g., NanoVibronix) pending detail emergence
Sector Themes(3)
- ◆
Financial services board activity spike (7+ firms) hints at regulatory-driven governance tuning or talent realignment post-2025 volatility
- ◆
Biotech/pharma leadership flux (7+ firms) correlates with innovation pipeline pressures, potential for strategic hires boosting pipelines
- ◆
Broad cross-sector year-end churn reflects standardized compliance but flags need for diversified portfolio hedges against turnover waves
Watch List(4)
- 👁
NanoVibronix - Sole high-risk rating amid biotech cluster; monitor for departure details signaling distress
- 👁
ServiceNow (materiality 4/10) - Key tech name; track for C-suite implications on growth trajectory
- 👁
Simmons First National & financial cluster - Volume suggests sector contagion; watch Q4 earnings for stability
- 👁
Six Flags & entertainment peers - Higher materiality; assess if changes tie to post-merger integration
Filing Analyses(43)
23-12-2025
ARVANA INC filed an 8-K on December 23, 2025, disclosing an Item 5.02 event related to departure of directors/officers, election/appointment of directors/officers, or compensatory arrangements. No specific details on officers, positions, reasons, or nature of change are provided in the summary. Analysis is constrained to metadata, indicating a routine disclosure without disclosed facts for deeper assessment.
- ·Item 5.02 filing on 2025-12-23 (AccNo: 0001713282-25-000833)
- ·Covers officer/director departures, elections, appointments, or compensation
- ·Sector: NOT_DISCLOSED; no names, positions, reasons, or quantitative data provided
23-12-2025
Peapack Gladstone Financial Corp filed a Form 8-K on December 23, 2025 (AccNo: 0001193125-25-330703, size 190 KB), disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers). Item 9.01 references Financial Statements and Exhibits. No specific details on the officer's name, position, reason for change, or compensatory arrangements are provided.
23-12-2025
The company filed an 8-K Item 5.02 on December 23, 2025 (AccNo: 0001193125-25-330865, Size: 144 KB), disclosing an officer change event dated December 23, 2025. No specific details on the officer's position, appointment or resignation status, reasons, or compensatory arrangements are provided. Sector is not specified.
23-12-2025
Six Flags Entertainment Corporation/NEW filed a Form 8-K on December 23, 2025 (AccNo: 0001193125-25-330990, Size: 130 KB), disclosing an Item 5.02 event related to departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on the key position affected, names, reasons for change, or any quantitative data are provided in the available information. Sector is not specified.
23-12-2025
The company filed an 8-K on December 23, 2025 (AccNo: 0001193125-25-330948, Size: 130 KB) disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers). Event type is Officer Change with date December 23, 2025; no specific details on position, person, reason, or type (appointment/resignation) are provided. Sector is not specified.
23-12-2025
Centuri Holdings, Inc. filed a Form 8-K on December 23, 2025 (AccNo: 0001981599-25-000102, Size: 141 KB), disclosing an officer change under Item 5.02. The item covers departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on individuals, reasons for change, compensation, or quantitative data are provided.
23-12-2025
Zivo Bioscience, Inc. filed a Form 8-K on December 23, 2025 (AccNo: 0001654954-25-014296, Size: 288 KB) disclosing an officer change under Item 5.02, covering departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements. Item 9.01 indicates financial statements and exhibits are included. No specific details on the officer, position, reason, or quantitative data are provided.
23-12-2025
Optex Systems Holdings Inc disclosed an officer change via Form 8-K filed on December 23, 2025 (AccNo: 0001493152-25-029014, Size: 196 KB) under Item 5.02, covering Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. No specific details on the affected officer, position, appointment/resignation status, reasons, or compensation are provided in the available information. Sector is not specified.
23-12-2025
NanoVibronix, Inc. filed a Form 8-K on December 23, 2025 (AccNo: 0001493152-25-029018, Size: 1 MB) disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers) and exhibits under Item 9.01. Specific details including the key position affected, whether it is an appointment or resignation, reasons for change, named individuals, or any quantitative data are NOT_DISCLOSED. Sector is not specified.
23-12-2025
Henry Schein Inc. filed an 8-K on December 23, 2025 (AccNo: 0001193125-25-330853, Size: 172 KB) disclosing an officer change under Item 5.02, covering departures of directors or certain officers, elections, appointments, or compensatory arrangements. Item 9.01 references financial statements and exhibits. No specific details on the officer position, appointment/resignation, reasons, or quantitative data are provided in the filing summary.
23-12-2025
Flora Growth Corp. filed a Form 8-K on December 23, 2025 (AccNo: 0001062993-25-017473, Size: 277 KB) disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers) and Item 9.01 (Financial Statements and Exhibits). No specific details on the affected position, individual, reason for change, or any quantitative data are provided in the filing summary. Sector is not specified.
23-12-2025
National CineMedia, Inc. filed a Form 8-K on December 23, 2025 (AccNo: 0001193125-25-330847, Size: 547 KB) disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers) and exhibits under Item 9.01 (Financial Statements and Exhibits). No specific details on the affected officer, position, appointment/resignation status, reasons, or compensation are provided in the summary. Sector is not specified.
23-12-2025
WW International, Inc. filed a Form 8-K on December 23, 2025 (AccNo: 0001193125-25-330852, Size: 152 KB), disclosing an officer change under Item 5.02 related to Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. No specific details on the officer's position, nature of change (appointment or resignation), reasons, or compensation are provided in the filing summary. Sector is not specified.
23-12-2025
MSA Safety Inc filed a Form 8-K on 2025-12-23 (AccNo: 0000066570-25-000044, Size: 176 KB) disclosing an officer change under Item 5.02, covering departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers. Item 9.01 lists financial statements and exhibits. No specific details on the affected officer, position, reason for change, or quantitative data are provided.
23-12-2025
Skillz Inc. filed a Form 8-K on December 23, 2025 (AccNo: 0001801661-25-000104, Size: 324 KB), disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers) and exhibits under Item 9.01. No specific details on the affected officer, position, reason for change, or any quantitative data are provided in the filing summary. Sector is not specified.
23-12-2025
Grid Dynamics Holdings, Inc. disclosed an officer change event via Form 8-K filed on December 23, 2025 (AccNo: 0001104659-25-124231, size 221 KB). The filing covers Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), Item 5.07 (Submission of Matters to a Vote of Security Holders), and Item 9.01 (Financial Statements and Exhibits). No specific details on personnel, reasons, votes, or exhibits provided.
23-12-2025
Company filed an 8-K on 2025-12-23 (AccNo: 0001193125-25-330926, Size: 140 KB) disclosing Item 5.02 event: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. Event Type: Officer Change, Date: December 23, 2025. No specific details on positions affected, names, reasons, or quantitative data provided.
23-12-2025
An unidentified company filed an 8-K on 2025-12-23 (AccNo: 0001193125-25-330932, Size: 144 KB) under Item 5.02 disclosing an unspecified officer change with event date December 23, 2025. No details on the officer's name, title, position (e.g., CEO, CFO), nature of change (appointment or resignation), reason, or internal/external status are provided. Sector is not specified.
23-12-2025
The company filed an 8-K on 2025-12-23 (AccNo: 0001193125-25-330944, Size: 130 KB) disclosing an Item 5.02 event categorized as Officer Change related to Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. The event date is December 23, 2025, with source us_sec and sector not specified. No specific details on positions affected, individuals involved, reasons for change, or quantitative data are provided.
23-12-2025
Morgan Stanley Direct Lending Fund filed a Form 8-K on December 23, 2025 (AccNo: 0001193125-25-330927, Size: 137 KB), disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers). No specific details on the officer's position, name, reason for change, appointment/resignation status, or any quantitative data are provided in the summary. Sector is not specified.
23-12-2025
Sharps Technology Inc. disclosed an officer change via Form 8-K filed on December 23, 2025, under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers). Filing details include AccNo: 0001493152-25-029023 and size: 250 KB. No specific details on the officer, position, reason, or nature of the change (appointment or departure) are provided.
23-12-2025
Southland Holdings, Inc. disclosed an officer change via Form 8-K filed on 2025-12-23 under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers). Accession Number: 0001829126-25-010277, file size 246 KB. No specific details on positions, individuals, reasons, or quantitative data provided in the filing summary; sector not specified.
23-12-2025
Custom Truck One Source, Inc. filed a Form 8-K on December 23, 2025 (AccNo: 0001709682-25-000043, Size: 140 KB) disclosing an officer change under Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. No specific details on the key position affected, individuals involved, appointment or resignation status, reasons, or timing are provided. Sector is not specified.
23-12-2025
Connect Biopharma Holdings Ltd filed a Form 8-K on December 23, 2025 (AccNo: 0001835268-25-000061, Size: 143 KB), disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers) and Item 9.01 (Financial Statements and Exhibits). No specific details on the affected officer, position (e.g., CEO, CFO), reason for change, appointment/resignation status, or any quantitative data are provided in the filing summary. Sector is not specified.
23-12-2025
Simmons First National Corp filed a Form 8-K on December 23, 2025 (AccNo: 0001193125-25-331015, Size: 185 KB) disclosing an officer change under Item 5.02, which covers departures of directors or certain officers, elections of directors, appointments of certain officers, and compensatory arrangements. Item 9.01 references financial statements and exhibits. No specific details on the officer, position, reason, or nature of the change (appointment or resignation) are provided.
23-12-2025
DeFi Development Corp. filed a Form 8-K on December 23, 2025 (AccNo: 0001213900-25-125412, Size: 546 KB) disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements). The filing also covers Item 5.07 (Submission of Matters to a Vote of Security Holders) and Item 9.01 (Financial Statements and Exhibits). No specific details on personnel, reasons, or outcomes are provided in the summary.
23-12-2025
USCB Financial Holdings, Inc. disclosed an officer change via Form 8-K filed on December 23, 2025, under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers) and Item 9.01 (Financial Statements and Exhibits). No specific details on the affected officer, position, appointment/resignation status, reasons, or compensation are provided in the filing summary. AccNo: 0000927089-25-000220; File size: 235 KB.
23-12-2025
ServiceNow, Inc. filed a Form 8-K on December 23, 2025 (AccNo: 0001373715-25-000335, Size: 340 KB) disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers) and Item 9.01 (Financial Statements and Exhibits). No specific details on the officer involved, position affected, nature of change (appointment or resignation), reasons, or any quantitative data are provided in the summary. Sector is not specified.
23-12-2025
Ginkgo Bioworks Holdings, Inc. disclosed an officer change via Form 8-K filed on 2025-12-23 (AccNo: 0001628280-25-058791, Size: 142 KB), under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers) and Item 8.01 (Other Events). No specific details on the affected officer, position, appointment/resignation status, reasons, or compensation provided. Sector not specified.
23-12-2025
Pelthos Therapeutics Inc. filed a Form 8-K on December 23, 2025 (AccNo: 0001753926-25-001964, Size: 231 KB), disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers). The filing also covers other events in Item 8.01 and financial statements/exhibits in Item 9.01. No specific details on the officer position, appointment/resignation status, reasons, or quantitative data are provided.
23-12-2025
Terra Innovatum Global N.V. filed a Form 8-K on December 23, 2025 (AccNo: 0001213900-25-125453, Size: 501 KB) disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers) and Item 9.01 (Financial Statements and Exhibits). No specific details on the affected officer, position, appointment/resignation status, reasons, or any quantitative data are provided in the filing summary. Sector not specified.
23-12-2025
Sensei Biotherapeutics, Inc. disclosed an officer change under Item 5.02 of Form 8-K filed on December 23, 2025 (AccNo: 0001193125-25-331113, Size: 143 KB). The filing pertains to Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. No specific details on the affected officer, position, appointment/resignation status, reasons, or quantitative data are provided.
23-12-2025
Comcast Corp filed an 8-K on December 23, 2025 (AccNo: 0001628280-25-058790, Size: 277 KB) under Item 5.02 disclosing matters related to Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. No specific details on individuals, positions, reasons for change, or quantitative data are provided in the filing summary. Sector is not specified.
23-12-2025
RxSight, Inc. disclosed an officer change event via Form 8-K filed on December 23, 2025 (AccNo: 0001193125-25-331151, size 149 KB). The filing covers Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers) and Item 7.01 (Regulation FD Disclosure). No specific details on positions, individuals, reasons, or quantitative data provided in the summary.
23-12-2025
Krystal Biotech, Inc. filed a Form 8-K on December 23, 2025 (AccNo: 0001711279-25-000092, Size: 138 KB) disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers). Item 9.01 references Financial Statements and Exhibits. No specific details on the officer involved, position affected, appointment/resignation status, reasons, or quantitative data are provided in the filing summary.
23-12-2025
Gencor Industries Inc filed an 8-K on December 23, 2025, disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election or Appointment; Compensatory Arrangements). Item 9.01 references financial statements and exhibits. No specific details on officer position, appointment/resignation, reasons, or quantitative data are provided in the filing summary.
- ·Item 5.02 indicates officer departure, election, appointment, or compensatory arrangement change
- ·Filed timely on 2025-12-23 (AccNo: 0001193125-25-329707)
- ·Sector not specified; no names, positions, reasons, or financial metrics disclosed
23-12-2025
Peraso Inc. filed an 8-K on 2025-12-23 disclosing an officer change under Item 5.02, shareholder vote results under Item 5.07, Regulation FD disclosure under Item 7.01, and exhibits under Item 9.01. No specific details on the officer position, appointment/resignation, reasons, or quantitative data provided in the summary. Analysis limited to filing items due to lack of filing content.
- ·Item 5.02 discloses departure/election of officers or directors; specifics NOT_DISCLOSED
- ·Item 5.07 reports shareholder vote outcomes; results NOT_DISCLOSED
- ·Item 7.01 provides Regulation FD disclosure; content NOT_DISCLOSED
- ·Quantitative data extraction: Transaction Value NOT_DISCLOSED, Share Count NOT_DISCLOSED, Percentage Changes NOT_DISCLOSED, Financial Metrics NOT_DISCLOSED
- ·All leadership details (position, reason, timing) NOT_DISCLOSED
23-12-2025
TransUnion filed a Form 8-K on December 23, 2025, disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements) and exhibits under Item 9.01. No specific details on the affected officer, position, appointment/resignation status, reasons, or quantitative data are provided in the summary. Analysis is limited, indicating a routine SEC disclosure with unknown implications.
- ·Item 5.02 covers officer departures, appointments, or compensatory arrangements - specifics NOT_DISCLOSED
- ·Filed on 2025-12-23, compliant with SEC 8-K timelines
- ·No quantitative data (transaction values, shares, percentages, financial metrics) extracted - all NOT_DISCLOSED
23-12-2025
Dyne Therapeutics, Inc. filed a Form 8-K on December 23, 2025 (AccNo: 0001193125-25-329511), disclosing an officer change under Item 5.02. This covers potential departure of directors or certain officers, election or appointment of directors/officers, or compensatory arrangements. No specific details on positions, individuals, reasons, or quantitative data are provided in the summary.
- ·Event Type: Officer Change
- ·SEC Item 5.02 disclosure
- ·Filed: 2025-12-23; Sector: not specified
23-12-2025
Zicix Corp filed a Form 8-K on December 23, 2025, under Item 5.02 disclosing an unspecified officer change involving departure, election, appointment, or compensatory arrangements. No details on the key position, individual names, appointment/resignation status, reasons, or quantitative data are provided. Sector is not specified, limiting assessment of implications.
- ·Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements
- ·Filed: 2025-12-23, AccNo: 0001683168-25-009312
- ·No quantitative data (Transaction Value: NOT_DISCLOSED, Share Count: NOT_DISCLOSED, Percentage Changes: NOT_DISCLOSED, Financial Metrics: NOT_DISCLOSED)
23-12-2025
Burke & Herbert Financial Services Corp. filed an 8-K on 2025-12-23 disclosing an officer change under Item 5.02 (Departure/Election/Appointment of Officers or Compensatory Arrangements) and exhibits under Item 9.01. No specific details on position affected, appointment/resignation status, reasons, or quantitative data are provided in the filing summary. Analysis limited to disclosed items; all other facts NOT_DISCLOSED.
- ·Item 5.02 triggered: Officer change or compensatory arrangement
- ·Filed timely per SEC 8-K requirements (within 4 business days)
- ·No names, positions, reasons, or financial metrics disclosed
Get daily alerts with 5 investment signals, 4 risk alerts, 4 opportunities and full AI analysis of all 43 filings
🇺🇸 More from United States
View all →March 25, 2026
US Pre-Market SEC Filings Roundup — March 25, 2026
US Pre-Market SEC Filings Roundup
March 24, 2026
US Merger & Acquisition SEC Filings — March 24, 2026
US Merger & Acquisition SEC Filings
March 24, 2026
US Executive Officer Management Changes SEC — March 24, 2026
US Executive Officer Management Changes SEC
March 24, 2026
US Corporate Distress Financial Stress SEC Filings — March 24, 2026
US Corporate Distress Financial Stress SEC Filings